NF2 BioSolutions

MARCH 25, 2024

That’s where our ‘Understanding NF2’ podcast steps in. Our mission is to foster a better understanding of NF2 and create a supportive community for those affected. Their stories of struggle, hope and triumph are at the heart of this episode, offering inspiration and insight to our listeners.

69

69

pharmaphorum

OCTOBER 14, 2022

The latest funding announcement follows the company’s $218 million Series A financing in December 2021 and brings the total capital raised to $386 million – enabling continuance of Odyssey’s mission to develop innovative medicines for serious human diseases. This includes targets once thought ‘undruggable’. “We

105

105

European Pharmaceutical Review

MARCH 5, 2024

He asserted that the biotech plans to handle this by “operating our own manufacturing facilities for both small molecule medicines and large molecule biologics to support ongoing clinical research and global commercialisation of our internally developed medicines.”

Medical Schools 96

Medical Schools 96

PQA

MARCH 28, 2024

A statement from our Board Chair, Susan Cantrell, followed the Innovaccer’s announcement at the HIMSS Global Health Conference & Exhibition in Orlando. In the spirit of PQA’s commitment to transparency, I want to share more with you about our history in creating PQS and what this sale means for our alliance.

Immunization 40

Immunization 40

European Pharmaceutical Review

DECEMBER 22, 2022

Our new state-of-the-art facility will bring mRNA manufacturing to UK shores, providing the UK public with access to pandemic response capabilities through Moderna COVID-19 vaccines and future respiratory virus vaccine candidates,” stated Stéphane Bancel, Chief Executive Officer of Moderna. “Our

Vaccines 130

Vaccines 130

PQA

DECEMBER 21, 2023

As we near the end of 2023, it’s a great time to reflect on our accomplishments this year. Certainly, each year brings its share of opportunities and challenges, and I’m proud of our progress as an alliance. PQA’s New Look: PQA unveiled our refreshed brand at the 2023 PQA Annual Meeting. this November. this November.

Immunization 59

Immunization 59

European Pharmaceutical Review

APRIL 16, 2024

The new partnership aligns with mAbxience’s mission “to deliver high-quality, affordable healthcare solutions across continents,” commented Jurgen Van Broeck, Global Commercial Director of mAbxience.

85

85

PQA

JANUARY 24, 2024

I serve as Chief Operating Officer and am a member of our executive leadership team. I lead PQA’s finance and operations team, and focus on creating an effective, collaborative, and efficient environment that helps advance PQA’s mission. What is your role at PQA? PQA has experienced tremendous growth over the past few years.

Documentation 40

Documentation 40

pharmaphorum

NOVEMBER 25, 2022

In our final interview from Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sits down with Paolo Borella, who runs the new VITA digital health accelerator in Italy. And Paolo reflects on the overall mission of the accelerator and how it fits into the larger vision of collaboration in digital health.

98

98

STAT

NOVEMBER 11, 2022

This is, you may recall, our treasured signal to daydream about weekend plans. That’s not my thing,” he said, adding that, “It just, sort of, the mission spoke to me. Not a moment too soon, yes? ” Continue to STAT+ to read the full story…

Vaccines 95

Vaccines 95

Pharmaceutical Technology

DECEMBER 21, 2022

To back the UK in its international efforts as part of the country’s “100 Days Mission” to lower the future pandemics’ impact, the MITC would offer direct access to pandemic response expertise. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Vaccines 140

Vaccines Communication 140

PQA

FEBRUARY 20, 2024

Importantly, our commitment is aligned with the CMS National Quality Strategy and the person-centered care principles that are part of CMS’ Meaningful Measures 2.0. Additionally, our principles for diversity, equity and inclusion will guide us to ensure that we hear and respond to historically underrepresented voices.

52

52

PQA

DECEMBER 20, 2023

At MedWatchers, quality is at the top of our priorities. The integration of AI and automation into our operations bolsters our efforts to enhance health outcomes and elevate the standard of patient care in an ever-evolving healthcare landscape.

Patient Care 81

Patient Care 81

STAT

SEPTEMBER 20, 2022

Our official mascot is bounding about the grounds in search of critters and we are happily brewing a cup of stimulation — our choice is bourbon pecan. Of course, we are busy foraging for items of interest and have selected a few to help you get started on your own mission at hand. As always, please feel free to join us.

Compounding 95

Compounding FDA 95

Pharmaceutical Technology

MARCH 16, 2023

“We see this collaboration as an investment in next-generation science and technology, allowing us to accelerate our understanding of human pathobiology and explore the potential of developing novel medicines through AI.” According to the company, Huntington’s disease affects nearly one in 10,000 people across the world.

93

93

Omnicell

JANUARY 10, 2023

We have encouraged all of our employees to reflect upon how integrity has played an integral role in the growth of Omnicell throughout its 30-year history, and how it will continue to be vital to every aspect of the company's future. In that spirit, our theme for Compliance Week 2022 is Integrity Inspires.

Omnicell 97

Omnicell Customer Service 97

PQA

MAY 10, 2023

Our fresh and modernized logo and color scheme reflect our positive, forward-looking view of the vital role of medications in health care – and our role in bringing the industry together to improve quality. That’s why “PQA” remains central to our image, identity and logo. PQA has a new look!

Communication 52

Communication 52

Pharmaceutical Technology

OCTOBER 25, 2022

BioMed X Institute founder and managing director Christian Tidona said: “Our new collaboration with Sanofi allows us to further extend our data science and AI expertise in Heidelberg, where we have developed an ideal incubation environment for biomedical innovation at the interface between academia and industry.”.

Immunization 98

Immunization 98

Pharmaceutical Technology

APRIL 17, 2023

NKGen CEO Paul Song said: “The team at Graf fully understands and appreciates our novel NK cell therapy platform technology and our overall mission to help patients in real clinical need, especially those with neurodegenerative diseases. “We Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

98

98

Hospital Pharmacy Europe

AUGUST 7, 2023

The polypill is currently marketed in 25 countries and the feasibility of extending its distribution to additional territories, including the United States, is under analysis.

Dosage 96

Dosage Hospitals 96

Pharmaceutical Technology

JUNE 5, 2023

PharmaEssentia founder and CEO Ko-Chung Lin stated: “Expanding our geographic reach is critical to our mission to address clear gaps in therapeutic options for people with myeloproliferative neoplasms (MPNs). This regional expansion is a logical extension of our growing leadership in the Americas, led by Meredith Manning.”

52

52

Pharmaceutical Technology

MAY 29, 2023

Iovance interim president and CEO Frederick Vogt said: “The BLA acceptance is a significant milestone in our mission to deliver lifileucel as the first individualised, one-time cell therapy for a solid tumour. No potential review concerns have been identified by the FDA following an initial evaluation.

FDA 52

FDA 52

Hospital Pharmacy Europe

APRIL 12, 2023

Hear the latest developments and innovations in cardiovascular care at a new free event being held in May 2023 In support of our mission to provide high-quality clinical education, Hospital Healthcare Europe , together with Hospital Pharmacy Europe, is proud to announce a new series of events in 2023: the HHE Clinical Excellence programme.

Hospitals 95

Hospitals 95

Pharmaceutical Technology

AUGUST 18, 2022

Atomwise CEO and co-founder Abraham Heifets said: “At Atomwise, our mission is to use our unique technology to make better medicines faster by unlocking targets that have been inaccessible to traditional small molecule discovery approaches. “We

Compounding 98

Compounding 98

Pharmaceutical Technology

APRIL 26, 2023

IN8bio CEO and co-founder William Ho stated: “Our goal is to achieve our ‘mission of cancer zero’ by eradicating cancer cells and improving patient outcomes. We eagerly anticipate enrolling our first Phase II patients for INB-400 later this year.”

FDA 52

FDA Chemotherapy Immunization 52

European Pharmaceutical Review

NOVEMBER 14, 2023

to continue expanding its business of “helping innovators manufacture much needed genetic medicines” Miller added that the acquisition will help to advance its mission into the next global stage of development to expand its capabilities.

94

94

European Pharmaceutical Review

NOVEMBER 30, 2023

As we continue to drive innovation and invest in the future, our mission is singularly focused on the development, manufacturing, distribution, and commercialisation of these medicines in Europe and in the world,” affirmed Jozef Belcik, Head of Commercial Europe & JANZ, Biocon Biologics Ltd.

103

103

Pharmaceutical Technology

APRIL 6, 2023

ImmunoGen president and CEO Mark Enyedy said: “Our agreement with Pharmakon strengthens our financial position as we execute against our strategic priorities, including accelerating the launch of ELAHERE and investing in our pipeline of next-generation ADCs.

52

52

Pharmaceutical Technology

APRIL 25, 2023

Lilly executive vice-president and diabetes and obesity president Mike Mason stated: “Our portfolio of therapies continues to make life better for people with diabetes, and we will continue this important mission while also increasing our focus on advancing our pipeline of potential breakthrough treatments.

52

52

Pharmaceutical Technology

JUNE 13, 2023

Ironwood Pharmaceuticals CEO Tom McCourt stated: “Today, Ironwood has broken new ground again in the history of LINZESS, extending the clinical utility of our blockbuster treatment to six to 17-year-olds seeking relief for functional constipation, a debilitating condition.

FDA 52

FDA 52

European Pharmaceutical Review

JULY 5, 2022

Providing inclusive businesses financing and technical assistance, the fund will complement the Global Health Unit’s mission of leveraging global, regional and local investment to support the training of healthcare professionals and aiding communities in running sustainable care systems. .

Vaccines 93

Vaccines 93

Pharmacy Is Right For Me

MAY 1, 2023

There are a lot of misconceptions and myths about careers in pharmacy and we’re on a mission to change that! Pharmacists work in a wide variety of practice settings and we highlight a portion of them on our Novel Practice Settings page. Let’s debunk some of the most common myths about pharmacy careers.

Community Pharmacies 130

Community Pharmacies Hospitals Vaccines 130

Omnicell

SEPTEMBER 5, 2022

Our mission at EnlivenHealth is to build and orchestrate the most advanced digital engagement technologies that are designed to help retail pharmacies and health plans keep their patients and members healthy and happy while strengthening their businesses results.

Independent Pharmacies 52

Independent Pharmacies Omnicell Communication 52

pharmaphorum

JANUARY 15, 2021

When I was young, I had a strong desire to make a difference, and making a difference is right at the heart of GSK’s mission.”. Our employees’ friends and colleagues understand the great work we’re doing, which has changed how they feel about working for GSK and how they are engaged in our mission”. “Our

Vaccines 105

Vaccines 105

pharmaphorum

JUNE 6, 2022

US drug prices have soared over the last several decades, causing, at times, financial hardship for patients and their families, so Cuban says he developed MCCPDC with a simple mission – “to be the low-cost provider of medications to patients.”. “And, of course, Truepill, who does our prescription fulfilment.”

Insurance 144

Insurance Labelling Hospitals 144

Pharmaceutical Technology

MAY 10, 2023

CTI BioPharma president, CEO and interim chief medical officer Adam Craig stated: “We are delighted to announce this transaction, which delivers a compelling all-cash premium to our shareholders while positioning CTI to unlock the full potential of Vonjo in treating myeloproliferative disease. “In

59

59

Pharmaceutical Technology

MARCH 17, 2023

We are excited to collaborate with these generous supporters of our mission. LCRF Scientific Advisory Board chair Katerina Politi said: “LCRF is honoured to continue its long legacy of identifying and supporting outstanding lung cancer research projects over the years. It is an exciting and promising area in lung cancer research.”

98

98